Photodiagnosis and Photodynamic Therapy
Volume 6, Issue 3 , Pages 214-220 , September 2009

23Na MRI longitudinal follow-up of PDT in a xenograft model of human retinoblastoma

  • Mihaela Lupu, PhD

      Affiliations

    • U759 INSERM, Bât.112, Centre Universitaire, F 91405 Orsay cedex, France
    • Institut Curie, Bât.112, Centre Universitaire, F 91405 Orsay cedex, France
    • Corresponding Author InformationCorresponding author at: Institut Curie, Bât.112, Centre Universitaire, F 91405 Orsay cedex, France. Tel.: +33 1 69 86 31 59; fax: +33 1 69 07 53 27.
    • ,
  • Carole D. Thomas

      Affiliations

    • U759 INSERM, Bât.112, Centre Universitaire, F 91405 Orsay cedex, France
    • Institut Curie, Bât.112, Centre Universitaire, F 91405 Orsay cedex, France
    • ,
  • Philippe Maillard

      Affiliations

    • Institut Curie, Bât.112, Centre Universitaire, F 91405 Orsay cedex, France
    • UMR 176 CNRS, Bât.112, Centre Universitaire, F 91405 Orsay cedex, France
    • ,
  • Bernard Loock

      Affiliations

    • Institut Curie, Bât.112, Centre Universitaire, F 91405 Orsay cedex, France
    • UMR 176 CNRS, Bât.112, Centre Universitaire, F 91405 Orsay cedex, France
    • ,
  • Benoit Chauvin

      Affiliations

    • Univ. Paris-Sud, EA 4041, Laboratoire de Chimie Analytique, IFR 141, F92296 Chatenay Malabry, France
    • ,
  • Isabelle Aerts

      Affiliations

    • Département d’Oncologie Pédiatrique, Institut Curie, F 75248, Paris cedex 05, France
    • ,
  • Alain Croisy

      Affiliations

    • U759 INSERM, Bât.112, Centre Universitaire, F 91405 Orsay cedex, France
    • Institut Curie, Bât.112, Centre Universitaire, F 91405 Orsay cedex, France
    • ,
  • Elodie Belloir

      Affiliations

    • U759 INSERM, Bât.112, Centre Universitaire, F 91405 Orsay cedex, France
    • Institut Curie, Bât.112, Centre Universitaire, F 91405 Orsay cedex, France
    • ,
  • Andreas Volk

      Affiliations

    • U759 INSERM, Bât.112, Centre Universitaire, F 91405 Orsay cedex, France
    • Institut Curie, Bât.112, Centre Universitaire, F 91405 Orsay cedex, France
    • ,
  • Joel Mispelter

      Affiliations

    • U759 INSERM, Bât.112, Centre Universitaire, F 91405 Orsay cedex, France
    • Institut Curie, Bât.112, Centre Universitaire, F 91405 Orsay cedex, France

References 

  1. Castano AP, Demidova TN, Hamblin MR. Mechanisms in photodynamic therapy: Part one—photosensitizers, photochemistry and cellular localization. Photodiagn Photodynamic Ther. 2004;1:279–293
  2. Castano AP, Demidova TN, Hamblin MR. Mechanisms in photodynamic therapy: Part three—photosensitizer pharmacokinetics, biodistribution, tumor localization and modes of tumor destruction. Photodiagn Photodynamic Ther. 2005;2:91–106
  3. Dhale J, Bagdonas S, Kaalhus O, Olsen G, Steen HB, Moan J. The bystander effect in photodynamic inactivation of cells. Biochem Biophys Acta. 2000;1475:273–280
  4. Dolmans DE, Fukumura D, Jain RK. Photodynamic therapy for cancer. Nat Rev Cancer. 2003;3:380–386
  5. Doz F, Brisse H, Stoppa-Lyonnet D, Sastre X, Zucker J-M, Desjardins L. Retinoblastoma. In: Arnold  editors. Paediatric oncology. 2004;p. 323–338London
  6. Thomas CD, Lupu M, Walczak C, Volk A, Mispelter J. Cisplatin treatment monitoring by sodium MRI relaxometry at 4.7T in colorectal tumors implanted on mice. Proc Int Soc Mag Reson Med. 2008;16:2795
  7. Babsky AM, Hekmatyar SK, Zhang H, Solomon JL, Bansal N. Application of 23Na MRI to monitor chemotherapeutic response in RIF-1 tumors. Neoplasia. 2005;7:658–666
  8. aLaville I, Pigaglio S, Blais , et al. Photodynamic efficiency of diethylene glycol-linked glycoconjugated porphyrins in human retinoblastoma cells. J Med Chem. 2006;49:2558–2567bMaillard PH, Loock B, Grierson DS, et al. In vitro photocytotoxicity of glycoconjugated porphyrins and chlorins in colorectal adenocarcinoma (HT29) and retinoblastoma (Y79) cell lines. Photodiagn Photodynamic Ther. 2007;4:261–268
  9. Whelton R, Michael-Titus A, Basra S, Grahn M. Distribution of Temoporfin, a new photosensiziter for photodynamic therapy of cancer in a murine tumor model. Photochem Photobiol. 1995;61:397–401
  10. Jockovich M-E, Piña Y, Alegret A, Cebulla C, Feuer W, Murray TG. Heterogeneous tumor vasculature in retinoblastoma. Retina. 2008;28:S81–S86
  11. Castano AP, Demidova TN, Hamblin MR. Mechanisms in photodynamic therapy: Part two—cellular signaling, cell metabolism and modes of cell death. Photodiagn Photodynamic Ther. 2005;2:1–23
  12. Chen B, Pogue BW, Hoopes PJ, Hassan T. Combining vascular and cellular targeting regimens enhances the efficacy of photodynamic therapy. Int J Radiat Oncol Biol Phys. 2005;61:1216–1226
  13. Stephan H, Boeloeni R, Eggert A, Bornfeld N, Schueler A. Photodynamic therapy in retinoblastoma: effects of verteporfin on retinoblastoma cell lines. Inv Ophthalmol Vis Sci. 2008;49:3158–3163
  14. Shareef MM, Cui N, Burikhanov R, et al. Role of tumor necrosis factor α and TRAIL in high dose radiation induced bystander signalling in lung adenocarcinoma. Cancer Res. 2007;67(24):11811–11820
  15. Dhale J, Steen HB, Moan J. The mode of cell death induced by photodynamic treatment depends on cell density. Photochem Photobiol. 1999;70(3):363–367

PII: S1572-1000(09)00142-2

doi: 10.1016/j.pdpdt.2009.10.009

Photodiagnosis and Photodynamic Therapy
Volume 6, Issue 3 , Pages 214-220 , September 2009

Article Tools

* Image Usage & Resolution